Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma

This cohort study examines the risk of skeletal-related events associated with the frequency of bisphosphonate treatment in patients with multiple myeloma.

Detalles Bibliográficos
Autores principales: Zhou, Jifang, Sweiss, Karen, Han, Jin, Ko, Naomi Y., Patel, Pritesh R., Chiu, Brian C.-H., Calip, Gregory S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316999/
https://www.ncbi.nlm.nih.gov/pubmed/34313746
http://dx.doi.org/10.1001/jamanetworkopen.2021.18410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316999/
https://www.ncbi.nlm.nih.gov/pubmed/34313746
http://dx.doi.org/10.1001/jamanetworkopen.2021.18410

Ejemplares similares